rhTNF

Now, due to the influence of various factors such as environmental pollution and people's life pressure, some people's physical fitness is getting worse and worse, and more and more people are suffering from tumors. Many people have already developed malignant tumors when they find out that they have tumors. In this case, it is almost impossible to completely cure the tumor, and the patient's life can only be prolonged by injecting sufficient human tumor necrosis factor. So, what is recombinant human tumor necrosis factor?

1. What is recombinant human tumor necrosis factor for injection?

Recombinant human tumor necrosis factor for injection is indicated for combination with NP and MVP chemotherapy regimens. It can be tried in patients with advanced non-small cell lung cancer who have failed to respond to other treatments or have relapsed. This product can be used in combination with the BACOP chemotherapy regimen for patients with advanced non-Hodgkin's lymphoma who have not responded to chemotherapy or other treatment methods.

2. Ingredients

Recombinant human tumor necrosis factor.

3. Properties

White or slightly yellow loose body

4. Indications

This product can be used in combination with NP and MVP chemotherapy regimens for patients with advanced non-small cell lung cancer who have failed to respond to other treatments or who have relapsed.

5. Specification: 5 million IU/bottle

6. Usage and Dosage

Used in combination with the above chemotherapy regimen, take the drug on the 3rd to 7th day of each week, with a dose of 600,000-900,000 units/m2, diluted to 20 ml with normal saline, and injected intravenously at a constant rate within 5-8 minutes.

7. Adverse reactions

In the clinical study of this product, a total of about 450 subjects received treatment with this product. In the trial, the short-term adverse reactions of this product for short-term treatment were mainly fever, cold-like symptoms, local pain after injection, local redness, swelling and nodules, and bone and muscle pain, with an incidence of about 80%. Four subjects discontinued treatment due to intolerance of fever. When the above-mentioned adverse reactions occur, appropriate symptomatic treatment measures can be taken.

Natural tumor necrosis factor is a multi-effect cytokine (see the above pharmacological actions). Its properties and characteristics may undergo complex changes after modification, which may cause adverse reactions and long-term follow-up effects on the hematopoietic system, immune system and nervous system. In particular, it may have a potential promoting effect on certain tumors and the occurrence of autoimmune-related diseases. Therefore, close attention should be paid to the long-term and potential adverse reactions of this product.

8. Taboo

1. This product is contraindicated for those who are allergic to its ingredients.

2. It is contraindicated for patients with severe liver, kidney, cardiopulmonary dysfunction.

3. Patients with other serious diseases who cannot tolerate the adverse reactions of this product are prohibited from using this product.